What is the situation in the year of our Lord 2014 about Phage therapy applications for bacterial infectious diseases treatment in human therapy ? Where we will be tomorrow ?
The answers to these questions demand a detailed analysis of the situation. It is exactly what I will do by the following layout:
1- Antibiotic resistance: a worldwide problem
2- List of Bacteria with a dangerous situation in human therapy regarding the antibiotic resistance
3- Situation of new drugs for bacterial infectious diseases treatment
4- Scientific literature regarding Phage therapy applications in human therapy
5-Mapping of Phage therapy companies:market situation,market trend, start up companies, close down companies and list of products
6- Mapping of researche centers working on Phage therapy
7- List of Phage therapy products at the experimental stage
8-Official Medicine position
9-Pharmaceutical companies position
10-Bureaucratic obstacles and delays
information
Whoever comes in this website may find a hint
Phage therapy is influenced by:
Phage therapy is influenced by:
Country : the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view
Country : the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view
From Wikipedia
If the target host* of a phage therapy treatment is not an animal the term "biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".
"In silico"
From:"Genomics,Proteomics and Clinical Bacteriology", N.Woodford and Alan P.Johnson
Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.